Baricitinib vs Canagliflozin

Baricitinib vs Canagliflozin: Overview

This comparison examines the pharmacological differences between Baricitinib and Canagliflozin.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Canagliflozin — 10.6 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Canagliflozin — C24H25FO5S.

Molecular Weight: Baricitinib — 371.4170 g/mol; Canagliflozin — 444.5170 g/mol.

Type: Baricitinib — Small molecule; Canagliflozin — Small molecule.